Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop
- 28 January 1999
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 18 (4), 1081-1091
- https://doi.org/10.1038/sj.onc.1202391
Abstract
The Mdm2 protein is frequently overexpressed in human non-seminomatous germ cell tumours and transitional carcinoma of the bladder where it may contribute to tolerance of wtp53. Mdm2 forms an autoregulatory feedback loop with p53; the Mdm2 gene is responsive to transactivation by p53 and once synthesized the Mdm2 protein terminates the p53 response. We show here that the topoisomerase poison etoposide, like ultra violet irradiation, inhibits Mdm2 synthesis. Cytotoxic concentrations of etoposide (IC90 for >3 h) result in inhibition of Mdm2 induction at both the RNA and protein level. Rapid apoptosis ensues. Global transcription is not inhibited: p21waf-1/cip-1 and GADD45 expression increase in a dose dependent manner. Inhibition of Mdm2 synthesis depends on the continuous presence of etoposide, suggesting the DNA damage may prevent transcription. Downregulation of Mdm2 transcript occurs in cells expressing HPV16-E6 suggesting that inhibition of Mdm2 transcription is p53-independent. When cells are treated with a pulse (1 h) of etoposide and reincubated in drug free medium, Mdm2 synthesis commences immediately after damage is repaired (3 h) and the p53 response is attenuated. Induction of apoptosis and loss of clonogenicity are 3 – 5-fold lower under pulse treatment conditions. This is the first observation of inhibition of Mdm2 transcription following treatment with topoisomerase (topo II) poisons, a feature that may be useful in tumour types where p53 is tolerated by overexpression of Mdm2.Keywords
This publication has 40 references indexed in Scilit:
- p53 binds to a constitutively nucleosome free region of the mdm2 geneOncogene, 1998
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2Oncogene, 1997
- Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoproteinNature, 1995
- Altered Patterns of MDM2 and TP53 Expression in Human Bladder CancerJNCI Journal of the National Cancer Institute, 1994
- Differential induction of transcriptionally active p53 following UV or lonizing radiation: Defects in chromosome instability syndromes?Cell, 1993
- Analysis of topoisomerase II‐mediated DNA cleavage of the c‐myc gene during HL60 differentiationFEBS Letters, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992